Venom immunotherapy in indolent systemic mastocytosis with high serum tryptase level
Mastocytosis is a rare group of disorders characterized by abnormal accumulation of mast cells in the skin, bone marrow, and internal organs. In particular, patients with systemic mastocytosis are at an increased risk of frequent and severe episodes of anaphylaxis. Hymenoptera venom allergy is the m...
Main Authors: | Ali Selcuk, Abdullah Baysan |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-06-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2020.1846398 |
Similar Items
-
Tryptase in children in the practice of an allergist
by: D. Sh. Macharadze
Published: (2023-03-01) -
Fatal <i>Hymenoptera</i> Venom–Triggered Anaphylaxis in Patients with Unrecognized Clonal Mast Cell Disorder—Is Mastocytosis to Blame?
by: Matija Rijavec, et al.
Published: (2023-11-01) -
Bone Marrow Mastocytosis: A Diagnostic Challenge
by: Roberta Zanotti, et al.
Published: (2021-04-01) -
Venom Immunotherapy: From Proteins to Product to Patient Protection
by: Martin Feindor, et al.
Published: (2021-09-01) -
Hymenoptera Venom Immunotherapy in Dogs: Safety and Clinical Efficacy
by: Ana Rostaher, et al.
Published: (2023-09-01)